Table 3.

CAC associated with PFS and OS by univariate and multivariate Cox regression analyses (P < .01)

CAC*Aberrationn (%)S0016B: Univariate Cox analysis, n = 246Multivariate Cox analysis, n = 230
LocationPHR95% CIPHR95% CI
PFS         
 17q Gain 45 (18) .0064 1.76 (1.17, 2.64) .010 1.80 (1.15, 2.70) 
OS         
 2p Gain 60 (24) .0024 2.35 (1.36, 4.08) .010 2.20 (1.21, 3.93) 
 2q Deletion 8 (3) .0018 4.37 (1.74, 11.03) .002 4.80 (1.77, 12.94) 
 8q Deletion 9 (4) .0001 5.40 (2.30, 12.67) .000 5.50 (2.25, 13.69) 
 16p Deletion 6 (2) .0002 5.75 (2.28, 14.52) .000 6.70 (2.52, 17.58) 
 17p Deletion 23 (9) .0024 2.91 (1.46, 5.80) .003 3.00 (1.47, 6.31) 
 22q Deletion 7 (3) .0007 5.00 (1.98, 12.65) .001 5.70 (2.07, 15.80) 
CAC*Aberrationn (%)S0016B: Univariate Cox analysis, n = 246Multivariate Cox analysis, n = 230
LocationPHR95% CIPHR95% CI
PFS         
 17q Gain 45 (18) .0064 1.76 (1.17, 2.64) .010 1.80 (1.15, 2.70) 
OS         
 2p Gain 60 (24) .0024 2.35 (1.36, 4.08) .010 2.20 (1.21, 3.93) 
 2q Deletion 8 (3) .0018 4.37 (1.74, 11.03) .002 4.80 (1.77, 12.94) 
 8q Deletion 9 (4) .0001 5.40 (2.30, 12.67) .000 5.50 (2.25, 13.69) 
 16p Deletion 6 (2) .0002 5.75 (2.28, 14.52) .000 6.70 (2.52, 17.58) 
 17p Deletion 23 (9) .0024 2.91 (1.46, 5.80) .003 3.00 (1.47, 6.31) 
 22q Deletion 7 (3) .0007 5.00 (1.98, 12.65) .001 5.70 (2.07, 15.80) 
*

All CAC are larger than 1 Mb.

Multivariate Cox analysis was performed with clinical covariates, including bulky disease, FLIPI risk, serum β2M, and elevated LDH level.

Close Modal

or Create an Account

Close Modal
Close Modal